نتائج البحث - "Giovanni Bertoldero"

المساهمون: Ferreri, Ajm, Sassone, M, Angelillo, P, Zaja, F, Re, A, Di Rocco, A, Spina, M, Fabbri, A, Stelitano, C, Frezzato, M, Volpetti, S, Zambello, R, Rusconi, C, De Lorenzo, D, Scarano, E, Arcari, A, Bertoldero, G, Nonis, A, Calimeri, T, Perrone, S, Cecchetti, C, Tarantino, V, Steffanoni, S, Foppoli, M, Ciceri, F, Ponzoni, M., Ferreri, A. J. M., Sassone, M., Angelillo, P., Zaja, F., Re, A., Di Rocco, A., Spina, M., Fabbri, A., Stelitano, C., Frezzato, M., Volpetti, S., Zambello, R., Rusconi, C., De Lorenzo, D., Scarano, E., Arcari, A., Bertoldero, G., Nonis, A., Calimeri, T., Perrone, S., Cecchetti, C., Tarantino, V., Steffanoni, S., Foppoli, M., Ciceri, F.

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lymphoma, Salvage therapy, Angiogenesis Inhibitors, 0302 clinical medicine, Autologous stem-cell transplantation, 80 and over, cell of origin, diffuse large B-cell lymphoma, immunomodulators, lenalidomide, maintenance, transformed high-grade lymphoma, Aged, 80 and over, immunomodulator, Hematology, General Medicine, Middle Aged, Prognosis, Diffuse, Survival Rate, Local, 030220 oncology & carcinogenesis, Female, Lymphoma, Large B-Cell, Diffuse, medicine.drug, Adult, medicine.medical_specialty, Neutropenia, Maintenance Chemotherapy, 03 medical and health sciences, Chemoimmunotherapy, Internal medicine, Large B-Cell, medicine, Humans, Autologous transplantation, Aged, Follow-Up Studies, Lenalidomide, Neoplasm Recurrence, Local, Salvage Therapy, Survival rate, business.industry, medicine.disease, Neoplasm Recurrence, business, Diffuse large B-cell lymphoma, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54117506a1c337643ec919449223e71fTest
http://hdl.handle.net/11573/1455021Test

10

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy

المصدر: Leukemia research. 74

مصطلحات موضوعية: Male, Cancer Research, Time Factors, 0302 clinical medicine, Generic imatinib, hemic and lymphatic diseases, Adverse events, Branded imatinib, Molecular response, Savings, Adult, Aged, Aged, 80 and over, Drugs, Generic, Female, Follow-Up Studies, Humans, Imatinib Mesylate, Italy, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Middle Aged, 80 and over, Expiration, Chronic, Leukemia, Drugs, Hematology, Oncology, 030220 oncology & carcinogenesis, Cohort, Bosutinib, medicine.drug, medicine.medical_specialty, Side effect, Generic, 03 medical and health sciences, Internal medicine, medicine, Adverse effect, business.industry, Cancer, Imatinib, medicine.disease, Nilotinib, BCR-ABL Positive, business, Myelogenous, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360b352630652d5635344e370a34be8cTest
https://pubmed.ncbi.nlm.nih.gov/30308414Test

تنقيح النتائج